259 related articles for article (PubMed ID: 21156040)
41. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
[TBL] [Abstract][Full Text] [Related]
42. Serum Lipid Profile and Its Association with Diabetes and Prediabetes in a Rural Bangladeshi Population.
Bhowmik B; Siddiquee T; Mujumder A; Afsana F; Ahmed T; Mdala IA; do V Moreira NC; Khan AKA; Hussain A; Holmboe-Ottesen G; Omsland TK
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200612
[TBL] [Abstract][Full Text] [Related]
43. Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study.
Trautwein EA; Koppenol WP; de Jong A; Hiemstra H; Vermeer MA; Noakes M; Luscombe-Marsh ND
Nutr Diabetes; 2018 May; 8(1):30. PubMed ID: 29795368
[TBL] [Abstract][Full Text] [Related]
44. Triglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride-glucose index for the diagnosis of metabolic syndrome using International Diabetes Federation criteria of insulin resistance in obese adolescents: a cross-sectional study.
Aslan Çin NN; Yardımcı H; Koç N; Uçaktürk SA; Akçil Ok M
J Pediatr Endocrinol Metab; 2020 May; 33(6):777-784. PubMed ID: 32447329
[TBL] [Abstract][Full Text] [Related]
45. Association between triglyceride to HDL-C ratio and insulin resistance in indigenous Argentinean children.
Hirschler V; Maccallini G; Sanchez M; Gonzalez C; Molinari C
Pediatr Diabetes; 2015 Dec; 16(8):606-12. PubMed ID: 25303644
[TBL] [Abstract][Full Text] [Related]
46. Associations Between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Metabolic Syndrome, Insulin Resistance, and Lifestyle Habits in Healthy Japanese.
Moriyama K
Metab Syndr Relat Disord; 2020 Jun; 18(5):260-266. PubMed ID: 32191558
[No Abstract] [Full Text] [Related]
47. Similarities and differences in cardiometabolic risk factors among remote Aboriginal Australian and Canadian cohorts.
Maple-Brown LJ; Brimblecombe J; Connelly PW; Harris SB; Mamakeesick M; Zinman B; O'Dea K; Hanley AJ
Diabetes Res Clin Pract; 2013 Apr; 100(1):133-41. PubMed ID: 23312484
[TBL] [Abstract][Full Text] [Related]
48. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance, β-cell function, and diabetes in Hispanics and African Americans.
Young KA; Maturu A; Lorenzo C; Langefeld CD; Wagenknecht LE; Chen YI; Taylor KD; Rotter JI; Norris JM; Rasouli N
J Diabetes Complications; 2019 Feb; 33(2):118-122. PubMed ID: 30522790
[TBL] [Abstract][Full Text] [Related]
49. Related cardiometabolic factors and prevalence of low HDL-cholesterol levels and atherogenic dyslipidemia. SIMETAP-AD study.
Ruiz-García A; Arranz-Martínez E; García-Fernández ME; Cabrera-Vélez R; García-Pliego RA; Morales-Cobos LE; Sanz-Pozo B; Gómez-Díaz E; Rodríguez-de-Mingo E; Rico-Pérez MR; Migueláñez-Valero A; Calderín-Morales MP; Sandín-de-Vega E; Hombrados-Gonzalo MP; Luna-Ramírez S; Sánchez-Ramos MC; Mora-Casado C; Moreno-Muñoz MS; González-Escobar P; Ruiz-Díaz L; Caballero-Ramírez N; Zamora-Gómez MM; Iturmendi-Martínez N; Holgado-Catalán MS; Álvarez-Benedicto R; Sanchidriá-Fernández PL; Benito-Alonso E; Fernández-Vicente T; Hernández-López RM; Doria-Carlin NA; Frías-Vargas MJ;
Clin Investig Arterioscler; 2021; 33(1):19-29. PubMed ID: 33082056
[TBL] [Abstract][Full Text] [Related]
50. Positive association between the ratio of triglycerides to high-density lipoprotein cholesterol and diabetes incidence in Korean adults.
Kim J; Shin SJ; Kim YS; Kang HT
Cardiovasc Diabetol; 2021 Sep; 20(1):183. PubMed ID: 34503545
[TBL] [Abstract][Full Text] [Related]
51. Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation.
Kozakova M; Morizzo C; Goncalves I; Natali A; Nilsson J; Palombo C
Cardiovasc Diabetol; 2019 May; 18(1):61. PubMed ID: 31077210
[TBL] [Abstract][Full Text] [Related]
52. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2012 Nov; 11():140. PubMed ID: 23150952
[TBL] [Abstract][Full Text] [Related]
53. Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
Rana JS; Visser ME; Arsenault BJ; Després JP; Stroes ES; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
Int J Cardiol; 2010 Sep; 143(3):399-404. PubMed ID: 19394708
[TBL] [Abstract][Full Text] [Related]
54. Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial.
Tsunoda F; Asztalos IB; Horvath KV; Steiner G; Schaefer EJ; Asztalos BF
Atherosclerosis; 2016 Apr; 247():35-39. PubMed ID: 26854974
[TBL] [Abstract][Full Text] [Related]
55. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.
Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV
Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840
[TBL] [Abstract][Full Text] [Related]
56. Associations of lipid parameters with insulin resistance and diabetes: A population-based study.
Lin D; Qi Y; Huang C; Wu M; Wang C; Li F; Yang C; Yan L; Ren M; Sun K
Clin Nutr; 2018 Aug; 37(4):1423-1429. PubMed ID: 28673690
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of dyslipidemia and the relationship between HbA1C and lipid profile in Moroccan patients with T2DM: a cross-sectional study.
Alami HE; Haddou I; Benaadi G; Lkhider M; Wakrim L; Allali M; Abidi O; Ghazal H; Idrissi NA; Nabih N; Naamane A; Maaroufi A; Khlil N; Hamdi S
Pan Afr Med J; 2022; 43():86. PubMed ID: 36605985
[TBL] [Abstract][Full Text] [Related]
58. The pattern of dyslipidemia among Somali type 2 diabetic patients: a cross-sectional study.
Alıcı G; Genç Ö
Eur J Med Res; 2022 Nov; 27(1):253. PubMed ID: 36404351
[TBL] [Abstract][Full Text] [Related]
59. Fatty liver and atherogenic dyslipidemia have opposite effects on diabetic micro- and macrovascular disease.
Hermans MP; Bouenizabila E; Daniel Amoussou-Guenou K; Jules Gninkoun C; Ahn SA; Rousseau MF
Diabetes Metab Syndr; 2022 Oct; 16(10):102613. PubMed ID: 36116326
[TBL] [Abstract][Full Text] [Related]
60. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
Bruckert E; Baccara-Dinet M; Eschwege E
Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
